What happened
On October 6, 2026, Hyperliquid Labs completed its monthly HYPE token unlock: 3.75 million tokens, roughly 38% of the 9.9 million the public vesting calendar had listed for release. Co-founder "iliensinc" said the entire batch is covered by an over-the-counter (OTC: a private trade negotiated directly between two parties rather than routed through an exchange's public order book) agreement with a single, undisclosed institutional buyer. At HYPE's October 6 price of roughly $92.60, the batch is worth about $337 million. Staked HYPE has to pass through a seven-day unstaking queue before it becomes transferable; that queue started around September 30, so the tokens reach the buyer's wallet around October 7, per FinanceFeeds and CryptoTimes reporting, which agree on the amount, the OTC structure, and the single-buyer detail.
The framework read
An unlock is a Tokenomics & Value Accrual question: the highest-weighted of the framework's six dimensions (28%), which tracks supply and emissions, unlock cliffs (who gets newly-unlocked supply, and when), and the gap between float (tokens actually tradable today) and FDV (fully diluted valuation, what the market cap would be if every token that will ever exist were circulating now). Two of the framework's nine hard gates sit nearby: a low float relative to FDV paired with an imminent unlock, and concentrated insider or team wallet supply. Neither gate is tripped by this event on its own: HYPE's unlock schedule has been public since token genesis in November 2024, and the transaction was disclosed rather than routed quietly through an exchange. But a single buyer absorbing 1.69% of released supply in one OTC trade is exactly the kind of concentration event those gates exist to watch, regardless of which side of the line it lands on.
The OTC structure matters more here than the dollar figure. Routing an unlock to a private buyer instead of the public order book avoids the immediate sell-side pressure a direct token dump would cause: open interest (the total number of outstanding derivatives contracts on HYPE) showed no spike in short positioning around the release, meaning traders weren't betting on a sell-off. That is a different risk profile than a cliff unlock hitting an order book, not a risk-free one: it relocates the overhang from "today's order book" to "whatever this buyer does next," and the buyer's intentions were not disclosed along with their existence.
What we're watching
Whether the buyer's allocation moves on-chain after the October 7 unstaking completes. A wallet that sits static for weeks reads as a long-term holder; a wallet that routes to exchanges reads as deferred sell pressure, not avoided sell pressure.
Whether Hyperliquid's buyback cadence holds. The protocol has been repurchasing roughly $11–15 million in HYPE weekly from protocol revenue. A buyback pace that keeps up with unlocked supply supports the "revenue funds the float" case; a slowing buyback alongside unlocks would undercut it.
Whether future monthly unlocks keep going OTC. One disclosed private sale is a data point. A pattern of OTC placement every month says something different about who is accumulating HYPE's unlocked supply than a pattern of order-book sales would.
The circulating-supply ratio. About 22.2% of the 1 billion max supply is in circulation as of October 6, 2026, per Tokenomist — meaning roughly 78% is still locked under vesting. Each unlock moves that ratio, and the float-to-FDV gap is the number the framework actually weighs — not the headline dollar figure attached to any single month's release.
None of this is a signal to act on today. It is a list of what would need to change in the data for an assessment to move — the distinction the framework exists to hold onto, including on a day the headline number sounds dramatic.
CryptoGrade publishes educational research, not investment advice. Ratings and commentary are produced by a rules-based framework applied identically to every asset. Crypto assets are volatile and you can lose your entire investment. Do your own research.